Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery

Clinical and Applied Thrombosis/Hemostasis

Volumn 14, Issue 4, 2008, Pages 472-475

  Sucker, Christoph ^a   Sabel, Michael ^a   Stummer, Walter ^a   Zotz, Rainer B ^a   Scharf, Ruediger E ^a   Gerhardt, Andrea ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Factor XI deficiency; Hemorrhage; NovoSeven; Recombinant activated factor VII; rFVIIa

Indexed keywords

BLOOD CLOTTING FACTOR 11; ENOXAPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CANCER SURGERY; CASE REPORT; DRUG DOSE REDUCTION; HEMOSTASIS; HUMAN; MALE; MENINGIOMA; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION;

BLOOD LOSS, SURGICAL; BRAIN NEOPLASMS; FACTOR VIIA; FACTOR XI DEFICIENCY; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 51849115661     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607305119     Document Type: Article

References (17)

1. Hedner U. Mechanism of action of recombinant activated factor VII: an update. Semin Hematol. 2006 ; 43 (1 Suppl). 105-107.
2. Batorova A., Lazur J., Cupanik V., Kotoucek P., Mistrik M. Successful treatment of postoperative bleeding with continuous infusion of recombinant factor VIIa in patient with severe factor XI deficiency and allergic reactions to plasma [abstract]. Thromb Haemost. 1999 ; 621 (Suppl): 1955.
3. Bern M., Sahud M., Zhukov O., Qu K., Mitchell W. Jr. Treatment of factor XI inhibitor using recombinant activated factor VIIa. Haemophilia. 2005 ; 11: 20-25.
4. Billon S., LeNiger C., Escoffre-Barbe M., Vicariot M., Abgrall JF The use of recombinant factor VIIa (NovoSeven®) in a patient with a factor XI deficiency and a circulating anticoagulant. Blood Coagul Fibrinolysis. 2001 ; 12: 551-553.
5. Brown SA What dose of recombinant activated factor VII should be used in patients with factor XI deficiency ? Haemophilia. 2005 ; 11: 430-431.
6. Castillo R. Patients treated on a compassionate use basis-case histories: in FXI deficiency. In: Hedner U, Roberts HR, eds. 2nd Symposium on New Aspects of Hemophilia Treatment. Bussum, Netherlands: Medicom Europe; 1991:137-139.
7. Lawler P., White B., Pye S., et al. Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency. Haemophilia. 2002 ; 8: 145-148.
8. O'Connell NM Factor XI deficiency-from molecular genetics to clinical management. Blood Coagul Fibrinolysis. 2003 ; 14 (1 Suppl). 59-64.
9. Schulman S., Nemeth H. An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency. Haemophilia. 2006 ; 12: 223-227.
10. Salomon O., Seligsohn U. New observations on factor XI deficiency. Haemophilia. 2004 ;(4 Suppl). 184-187.
11. O'Connell NM Factor XI deficiency. Semin Hematol. 2004 ; 41 (1 Suppl). 76-81.
12. Salomon O., Zivelin A., Livnat T., et al. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood. 2003 ; 101: 4783-4788.
13. Bolton-Maggs PH, Colvin BT, Satchi BT, Lee CA, Lucas GA Thrombogenic potential of factor XI concentrate. Lancet. 1994 ; 344: 748-749.
14. Gitel SN, Caron D., Schulman S., Martinowitz U. Clinical experiences of a F XI concentrate: possible side-effects. Thromb Haemost. 1991 ; 65: 1157.
15. Salomon O., Zivelin A., Livnat T., Seligsohn U. Inhibitors to Factor XI in patients with severe Factor XI deficiency. Semin Hematol. 2006 ; 43 (1 Suppl). 10-12.
16. Brodsky JB, Burgess GE III. Pulmonary embolism with factor XI deficiency. JAMA. 1975 ; 234: 1156-1157.
17. Mayer SA, Brun NC, Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005 ; 352: 777-785.